Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
144
NCT04015076
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 16, 2019
Completion: Mar 23, 2020
NCT04086602
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
Start: Sep 13, 2019
Completion: Feb 4, 2020
NCT04338997
PK Study in Patients With Parkinson's Disease With IZD174
Start: Oct 31, 2020
Completion: Dec 31, 2020